Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of mouse Sod2-/- and Sod2+/+ erythroblasts.
The mitochondrial superoxide dismutase (SOD2) is a major antioxidant protein which detoxifies superoxide anion radicals generated by mitochondrial respiration (Weisiger and Fridovich, J. Biol. Chem. 1973). We designed a model of oxidative stress-induced anemia caused by SOD2-deficiency (Friedman et...
ORGANISM(S): Mus musculus 
2008-10-25 | E-GEOD-8726 | biostudies-arrayexpress
UnknownSATB2 organizes the 3D genome architecture of cognition in cortical neurons.
Not available
S-EPMC10923151 | biostudies-literature
UnknownIn vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk gene.
Not available
S-EPMC6739341 | biostudies-literature
UnknownA chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons.
Not available
S-EPMC7031924 | biostudies-literature
TranscriptomicsArray results for differential gene expression in 661W, a mouse cone photoreceptor-derived cell line, comparing cells incubated with vehicle controls vs. those treated with either of two 7-dehdyrocholesterol-derived oxysterols or cholesterol
RELEVANCE: Smith-Lemli-Opitz syndrome (SLOS) is a human disease caused by mutations in the gene coding for the enzyme DHCR7 (7-dehydrocholesterol (7DHC) reductase), which catalyzes the final step of cholesterol biosynthesis. Accumulated 7DHC in tissues and body fluids of SLOS patients gives rise t...
ORGANISM(S): Mus musculus 
2021-03-20 | E-MTAB-10055 | biostudies-arrayexpress
UnknownGlobal landscape and genetic regulation of RNA editing in cortical samples from individuals with schizophrenia.
Not available
S-EPMC6791127 | biostudies-literature
UnknownDomains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.
Not available
S-EPMC12067843 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
UnknownOverall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
Sort   by:  
 Page size